Management of nonfunctioning pituitary incidentaloma

Affiliation auteurs!!!! Error affiliation !!!!
TitreManagement of nonfunctioning pituitary incidentaloma
Type de publicationJournal Article
Year of Publication2015
AuteursGalland F, Vantyghem M-C, Cazabat L, Boulin A, Cotton F, Bonneville J-F, Jouanneau E, Vidal-Trecan G, Chanson P
JournalANNALES D ENDOCRINOLOGIE
Volume76
Pagination191-200
Date PublishedJUL
Type of ArticleArticle
ISSN0003-4266
Mots-clésMacroadenoma, Microadenoma, Nonfunctioning pituitary incidentaloma
Résumé

Prevalence of pituitary incidentaloma is variable: between 1.4% and 27% at autopsy, and between 3.7% and 37% on imaging. Pituitary microincidentalomas (serendipitously discovered adenoma < 1 cm in diameter) may increase in size, but only 5% exceed 10 mm. Pituitary macroincidentalomas (serendipitously discovered adenoma > 1 cm in diameter) show increased size in 20-24% and 34-40% of cases at respectively 4 and 8 years' follow-up. Radiologic differential diagnosis requires MRI centered on the pituitary gland. Initial assessment of nonfunctioning (NF) microincidentaloma is firstly clinical, the endocrinologist looking for signs of hypersecretion (signs of hyperprolactinemia, acromegaly or Cushing's syndrome), followed up by systematic prolactin and IGF-1 assay initial assessment of NF macroincidentaloma is clinical, the endocrinologist looking for signs of hormonal hypersecretion or hypopituitarism, followed up by hormonal assay to screen for hypersecretion or hormonal deficiency and by ophthalmologic assessment (visual acuity and visual field) if and only if the lesion is near the optic chiasm (OC). NF microincidentaloma of less than 5 mm requires no surveillance; those of > 5 mm are not operated on but rather monitored on MRI at 6 months and then 2 years. Macroincidentaloma remote from the OC is monitored on MRI at 1 year, with hormonal exploration (for anterior pituitary deficiency), then every 2 years. When macroincidentaloma located near the OC is managed by surveillance rather than surgery, MRI is recommended at 6 months, with hormonal and visual exploration, then annual MRI and hormonal and visual assessment every 6 months. Surgery is indicated in the following cases: evolutive NF microincidentaloma, NF macroincidentaloma associated with hypopituitarism or showing progression, incidentaloma compressing the OC, possible malignancy, non-compliant patient, pregnancy desired in the short-term, or context at risk of apoplexy. (C) 2015 Elsevier Masson SAS. All rights reserved.

DOI10.1016/j.ando.2015.04.004